HCC
SNV

Hirtle Callaghan & Co’s Synovus SNV Stock Holding History

Hirtle Callaghan & Co’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-129
Closed -$4K – 312
2014
Q4 		$4K Sell
129
-778
-86% -$19.7K ﹤0.01% 472
2014
Q3 		$3K Hold
907
– – ﹤0.01% 530
2014
Q2 		$3K Buy
907
+777
+598% +$18.1K ﹤0.01% 559
2014
Q1 		$3K Hold
130
– – ﹤0.01% 546
2013
Q4 		$3K Hold
130
– – ﹤0.01% 523
2013
Q3 		$3K Hold
130
– – ﹤0.01% 536
2013
Q2 		$3K Buy
+130
New +$2.46K 0.03% 56

Other funds holding SNV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hirtle Callaghan & Co's SNV Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Synovus (SNV) in Q1 2015, closing a stake of 129 shares — an estimated $4K sold.

Hirtle Callaghan & Co first reported a position in SNV in Q2 2013 and held it in 7 quarters. The position peaked at $4K in Q4 2014. 252 funds tracked by Wall St. Rank hold SNV as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining Synovus position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 129 Synovus shares in Q1 2015, an estimated $4K.
  • Hirtle Callaghan & Co first reported a position in Synovus in Q2 2013 and held it in 7 quarters.
  • Hirtle Callaghan & Co's Synovus position peaked at $4K in Q4 2014.
  • 252 funds tracked by Wall St. Rank held Synovus as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.